Skip to content

HPPH

DRUG15 trials

Sponsors

Roswell Park Cancer Institute

Conditions

Adenocarcinoma of the LungBarrett's EsophagusCISCarcinoma of the Oral CavityCarcinoma of the OropharynxDysplasiaEsophageal CancerHGD

Phase 1

Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer
CompletedNCT00017485
Roswell Park Cancer InstituteNon-melanomatous Skin Cancer
Start: 2000-01-31End: 2007-01-31Updated: 2011-03-07
Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors
CompletedNCT00060268
Roswell Park Cancer InstituteEsophageal Cancer
Start: 1997-01-31End: 2004-06-30Updated: 2011-03-09
Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer
CompletedNCT00025571
Roswell Park Cancer InstituteLung Cancer
Start: 2001-06-30End: 2004-10-31Updated: 2011-03-07
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer
CompletedNCT00470496
Roswell Park Cancer InstituteRecurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Basal Cell Carcinoma of the Lip, Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity +52
Start: 2006-10-19End: 2018-08-30Updated: 2022-07-25
Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer
CompletedNCT00526461
Roswell Park Cancer InstituteLung Cancer
Start: 2004-02-29End: 2014-04-30Updated: 2023-08-04
Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer
TerminatedNCT00670397
Roswell Park Cancer InstituteHead and Neck Cancer
Start: 2010-06-30End: 2015-07-31Updated: 2016-03-16
Photodynamic Therapy Using HPPH in Treating Patients With Dysplasia, Cancer in Situ, or Invasive Cancer of the Larynx
CompletedNCT00675233
Roswell Park Cancer InstituteHead and Neck Cancer
Start: 2008-04-25End: 2018-09-27Updated: 2018-10-17
A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx
CompletedNCT01140178
Roswell Park Cancer InstituteCarcinoma of the Oral Cavity, Carcinoma of the Oropharynx, Dysplasia
Start: 2010-06-08End: 2018-10-01Updated: 2018-10-16
Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus
CompletedNCT01236443
Roswell Park Cancer InstituteBarrett's Esophagus, CIS, High Grade Dysplasia
Start: 2000-08-31End: 2013-04-30Updated: 2014-01-13
Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus
CompletedNCT01238042
Roswell Park Cancer InstituteBarrett's Esophagus, CIS, HGD
Start: 2003-03-31End: 2014-11-30Updated: 2014-12-02
Photodynamic Therapy in Treating Patients With Lung Cancer
CompletedNCT01668823
Roswell Park Cancer InstituteAdenocarcinoma of the Lung, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer +2
Start: 2004-02-29End: 2014-06-30Updated: 2014-07-31

Phase 2

Related Papers

JAMA Otolaryngology–Head & Neck Surgery2013-07-0166 citations